litlas
Log inCreate account

Samuel Leung

Active 1986–2025

102
Papers
25,407
Citations
66
h-index
96
i10-index

Citations

Citations per year for Samuel Leung1986: 1 citations1987: 1 citations1989: 3 citations1990: 2 citations1991: 1 citations1992: 2 citations1993: 1 citations1994: 1 citations1995: 1 citations1996: 1 citations1998: 2 citations1999: 2 citations2000: 4 citations2001: 3 citations2002: 2 citations2003: 5 citations2004: 1 citations2005: 3 citations2006: 4 citations2007: 6 citations2008: 27 citations2009: 83 citations2010: 185 citations2011: 245 citations2012: 273 citations2013: 262 citations2014: 269 citations2015: 282 citations2016: 385 citations2017: 374 citations2018: 372 citations2019: 982 citations2020: 1,105 citations2021: 1,103 citations2022: 889 citations2023: 724 citations2024: 1,057 citations2025: 528 citations2026: 29 citations1988: no citations, so this year is not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,820 citing papers, 23.8% of this breakdownChina: 1,173 citing papers, 9.9% of this breakdownUnited Kingdom: 782 citing papers, 6.6% of this breakdownCanada: 741 citing papers, 6.3% of this breakdownItaly: 728 citing papers, 6.1% of this breakdownGermany: 503 citing papers, 4.3% of this breakdownSpain: 409 citing papers, 3.5% of this breakdownFrance: 396 citing papers, 3.3% of this breakdownAustralia: 370 citing papers, 3.1% of this breakdownNetherlands: 324 citing papers, 2.7% of this breakdownJapan: 267 citing papers, 2.3% of this breakdownSweden: 240 citing papers, 2% of this breakdown
0%23.8%Other 26.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology44.5%
  • Medicine42.8%
  • Computer Science7.4%
  • Immunology and Microbiology2%
  • Engineering1%
  • Chemistry0.7%
  • Other1.6%

Topics

  • Breast Cancer Treatment Studies6.7%
  • Cancer Genomics and Diagnostics3.9%
  • Endometrial and Cervical Cancer Treatments3.9%
  • AI in cancer detection3.4%
  • Cancer Immunotherapy and Biomarkers3.3%
  • Cancer Cells and Metastasis3.2%
  • Other75.6%

Coauthors

All papers

Open in search
  1. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

    Authors: Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang, Samuel Leung, David Voduc, Tammi L. Vickery, Sherri R. Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu, John F. Quackenbush, Inge J. Stijleman, Juan Palazzo, J. S. Marron, Andrew B. Nobel, Elaine R. Mardis, Torsten O. Nielsen, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard - Journal of Clinical Oncology 2009 cited by 4,887

  2. Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer

    Authors: Aline Talhouk, Melissa K. McConechy, Samuel Leung, Winnie Yang, Amy Lum, Janine Senz, Niki Boyd, J.A. Pike, Michael S. Anglesio, Janice S. Kwon, Anthony N. Karnezis, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine - Cancer 2017 cited by 960

  3. A clinically applicable molecular-based classification for endometrial cancers

    Authors: Aline Talhouk, Melissa K. McConechy, Samuel Leung, Hector Li-Chang, Janice S. Kwon, Nataliya Melnyk, Winnie Yang, Janine Senz, Niki Boyd, Anthony N. Karnezis, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine - British Journal of Cancer 2015 cited by 944

  4. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

    Authors: Stefan Kommoss, Melissa K. McConechy, F. Kommoss, Samuel Leung, Anne-Kathrin Bunz, Jamie Magrill, Heidi Britton, F. Kommoss, Friederike Grevenkamp, Anthony N. Karnezis, Winnie Yang, Amy Lum, B. Krämer, Florin‐Andrei Taran, Annette Staebler, S. Lax, S Brücker, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine, Aline Talhouk - Annals of Oncology 2018 cited by 756

  5. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

    Authors: Torsten O. Nielsen, Samuel Leung, David L. Rimm, Andrew Dodson, Balázs Ács, Sunil Badve, Carsten Denkert, Matthew J. Ellis, Susan Fineberg, Margaret Flowers, Hans Kreipe, Anne‐Vibeke Lænkholm, Hongchao Pan, Frédérique Penault‐Llorca, Mei‐Yin C. Polley, Roberto Salgado, Ian E. Smith, Tomoharu Sugie, John M.S. Bartlett, Lisa M. McShane, Mitch Dowsett, Daniel F. Hayes - JNCI Journal of the National Cancer Institute 2020 cited by 733

  6. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

    Authors: Fanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, Zhifeng Dong, Julianna Blagih, Matthew G. Annis, Atilla Ömeroğlu, Dongxia Gao, Samuel Leung, Eitan Amir, Mark Clemons, Adriana Aguilar‐Mahecha, Mark Basik, Emma E. Vincent, Julie St‐Pierre, Russell G. Jones, Peter M. Siegel - Cell Metabolism 2015 cited by 556

  7. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

    Authors: Maggie C.U. Cheang, Stephen Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri R. Davies, Philip S. Bernard, Joel S. Parker, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen - JNCI Journal of the National Cancer Institute 2009 cited by 2,220

  8. Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival

    Authors: Andrew H. Beck, Ankur R. Sangoi, Samuel Leung, Robert J. Marinelli, Torsten O. Nielsen, Marc J. van de Vijver, Robert B. West, Matt van de Rijn, Daphne Koller - Science Translational Medicine 2011 cited by 793

  9. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

    Authors: Brett Wallden, James J. Storhoff, Torsten O. Nielsen, Naeem Dowidar, Carl Schaper, Sean Ferree, Shuzhen Liu, Samuel Leung, Gary Geiss, Jacqueline Snider, Tammi L. Vickery, Sherri R. Davies, Elaine R. Mardis, Michael Gnant, Ivana Šestak, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard, Joel S. Parker - BMC Medical Genomics 2015 cited by 560

  10. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

    Authors: Roberto A. Leon‐Ferre, Sarah Flora Jonas, Roberto Salgado, Sherene Loi, Vincent de Jong, Jodi M. Carter, Torsten O. Nielsen, Samuel Leung, Nazia Riaz, Stephen Chia, Gérôme Jules-Clément, Giuseppe Curigliano, Carmen Criscitiello, Vincent Cockenpot, Matteo Lambertini, Vera J. Suman, Barbro Linderholm, John W.M. Martens, Carolien H. M. van Deurzen, Anne Timmermans, Tatsunori Shimoi, Shu Yazaki, Masayuki Yoshida, Sung‐Bae Kim, Hee Jin Lee, Maria Vittoria Dieci, Guillaume Bataillon, Anne Vincent‐Salomon, Fabrice André, Marleen Kok, Sabine C. Linn, Matthew P. Goetz, Stefan Michiels, International Immuno-Oncology Biomarker Working Group - JAMA 2024 cited by 199

  11. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis

    Authors: Jessica N. McAlpine, Derek S. Chiu, Remi A. Nout, David N. Church, Pascal Schmidt, Stéphanie Lam, Samuel Leung, Stefania Bellone, Adele Wong, Sara Y. Brucker, Cheng‐Han Lee, Blaise Clarke, David G. Huntsman, Marcus Q. Bernardini, Joanne Ngeow, Alessandro D. Santin, Paul J. Goodfellow, Douglas A. Levine, Martin Köbel, Stefan Kommoss, Tjalling Bosse, C. Blake Gilks, Aline Talhouk - Cancer 2021 cited by 156

  12. Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death

    Authors: Amy Jamieson, Jutta Huvila, Derek S. Chiu, Emily F. Thompson, Stephanie Scott, Shannon Salvador, Danielle Vicus, Limor Helpman, Walter H. Gotlieb, Sarah Kean, Vanessa Samouëlian, Martin Köbel, Mary Kinloch, Carlos Parra-Harran, Saul Offman, Katherine Grondin, Julie Irving, Amy Lum, Janine Senz, Samuel Leung, Melissa K. McConechy, Marie Plante, Stefan Kommoss, David G. Huntsman, Aline Talhouk, C. Blake Gilks, Jessica N. McAlpine - Modern Pathology 2023 cited by 104

  13. Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors

    Authors: Yuanmei Lou, Paul C. McDonald, Arusha Oloumi, Stephen Chia, Christina Ostlund, Ardalan Ahmadi, Alastair H. Kyle, Ulrich auf dem Keller, Samuel Leung, David Huntsman, Blaise Clarke, Brent W. Sutherland, Dawn Waterhouse, Marcel B. Bally, Calvin D. Roskelley, Christopher M. Overall, Andrew I. Minchinton, Fabio Pacchiano, Fabrizio Carta, Andrea Scozzafava, Nadia Touisni, Jean‐Yves Winum, Claudiu T. Supuran, Shoukat Dedhar - Cancer Research 2011 cited by 756

  14. A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

    Authors: Torsten O. Nielsen, Joel S. Parker, Samuel Leung, D. Voduc, Mark Ebbert, Tammi L. Vickery, Sherri R. Davies, Jacqueline Snider, Inge J. Stijleman, Jerry P. Reed, Maggie C.U. Cheang, Elaine R. Mardis, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis - Clinical Cancer Research 2010 cited by 824

  15. An International Ki67 Reproducibility Study

    Authors: Mei‐Yin C. Polley, Samuel Leung, Lisa M. McShane, Dongxia Gao, Judith Hugh, Mauro G. Mastropasqua, Giuseppe Viale, Lila Zabaglo, Frédérique Penault‐Llorca, John M.S. Bartlett, Allen M. Gown, W. Fraser Symmans, Tammy Piper, Erika Mehl, Rebecca A. Enos, Daniel F. Hayes, Mitch Dowsett, Torsten O. Nielsen - JNCI Journal of the National Cancer Institute 2013 cited by 598

  16. Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

    Authors: Martin Köbel, Steve E. Kalloger, Niki Boyd, Steven McKinney, Erika Mehl, Chana Palmer, Samuel Leung, Nathan J. Bowen, Diana N. Ionescu, Ashish Rajput, Leah Prentice, Dianne Miller, Jennifer L. Santos, Kenneth D. Swenerton, C. Blake Gilks, David G. Huntsman - PLoS Medicine 2008 cited by 820

  17. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas

    Authors: Melissa K. McConechy, Aline Talhouk, Hector Li-Chang, Samuel Leung, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine - Gynecologic Oncology 2015 cited by 219

  18. CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

    Authors: Shuzhen Liu, Jonathan Lachapelle, Samuel Leung, Dongxia Gao, William D. Foulkes, Torsten O. Nielsen - Breast Cancer Research 2012 cited by 433

  19. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration

    Authors: Shuzhen Liu, William D. Foulkes, Samuel Leung, Dongxia Gao, Sherman Lau, Zuzana Kos, Torsten O. Nielsen - Breast Cancer Research 2014 cited by 243

  20. Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis

    Authors: Melissa K. McConechy, Aline Talhouk, Samuel Leung, Derek S. Chiu, Winnie Yang, Janine Senz, Linda J. Reha-Krantz, Cheng‐Han Lee, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine - Clinical Cancer Research 2016 cited by 189

  21. Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases

    Authors: Amy Jamieson, Emily F. Thompson, Jutta Huvila, Samuel Leung, Amy Lum, Chantale Morin, Kaoutar Ennour‐Idrissi, Alexandra Sebastianelli, Marie‐Claude Renaud, Jean‐Pierre Grégoire, David G. Huntsman, C. Blake Gilks, Marie Plante, Katherine Grondin, Jessica N. McAlpine - Gynecologic Oncology 2022 cited by 72

  22. Prognostic gene expression signature for high-grade serous ovarian cancer

    Authors: Joshua Millstein, Timothy Budden, Ellen L. Goode, Michael S. Anglesio, Aline Talhouk, Maria P. Intermaggio, Huei San Leong, Shuang Chen, Wafaa Elatre, C. Blake Gilks, Tayyebeh M. Nazeran, Mila Volchek, Rex C. Bentley, C. Wang, Derek S. Chiu, Stefan Kommoss, Samuel Leung, Janine Senz, Amy Lum, Vickie Chow, Hanwei Sudderuddin, Robertson Mackenzie, Joshy George, David D.L. Bowtell, Georgia Chenevix‐Trench, A. Green, Penelope M. Webb, Anna DeFazio, Dorota M. Gertig, Nadia Traficante, Sián Fereday, Sue Moore, Jillian A. Hung, K.R. Harrap, T. Sadkowsky, Nirmala Pandeya, M. Malt, Anne Mellon, R. Paul Robertson, T. Vanden Bergh, Marsha Jones, P. Mackenzie, J. Maidens, K. Nattress, Yoke-Eng Chiew, Annie Stenlake, Harold C. Sullivan, B. Alexander, P. Ashover, Scott D. Brown, T. Corrish, L. Green, L. M. Jackman, Kaltin Ferguson, Karla Martin, A. Martyn, B. Ranieri, Jeff White, V. Jayde, Pamela Mamers, Leanne Bowes, Laura Galletta, Daniel A. Giles, Joy Hendley, Kathryn Alsop, Tannin A. Schmidt, H. Shirley, Colleen T. Ball, Christian D. Young, S. Viduka, Hoa Tran, Sanela Bilic, Lydia Glavinas, Julia Brooks, R. Stuart‐Harris, Fred Kirsten, J Rutovitz, P. Clingan, Akisha Glasgow, Anthony Proietto, Stephen Braye, Geoffrey Otton, Jenny Shannon, Tony Bonaventura, Jocelyn M. Stewart, Stephen Begbie, Michael Friedländer, Dany Bell, Sally Baron‐Hay, A. Ferrier, G. Gard, David Nevell, Nick Pavlakis, Susan Valmadre, B. Young, C. Camaris, R. Crouch, L. Edwards, Neville F. Hacker, Donald E. Marsden and 180 more - Annals of Oncology 2020 cited by 173

  23. Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma

    Authors: Heidi Britton, Leo Huang, Amy Lum, Samuel Leung, Kathryn Shum, Mruganka Kale, Angela Burleigh, Janine Senz, Winnie Yang, Melissa M. McConechy, Stefan Kommoss, Sara Y. Brucker, Aline Talhouk, C. Blake Gilks, Jessica N. McAlpine - Gynecologic Oncology 2019 cited by 109

  24. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer

    Authors: Amy Jamieson, Jutta Huvila, Samuel Leung, Derek S. Chiu, Emily F. Thompson, Amy Lum, Mary Kinloch, Limor Helpman, Shannon Salvador, Danielle Vicus, Sarah Kean, Vanessa Samouëlian, Katherine Grondin, Julie Irving, Saul Offman, Carlos Parra‐Herran, Susie Lau, Stephanie Scott, Marie Plante, Melissa K. McConechy, David G. Huntsman, Aline Talhouk, Stefan Kommoss, C. Blake Gilks, Jessica N. McAlpine - Gynecologic Oncology 2023 cited by 36